To assess the importance of various risk factors for breast cancer in women with benign proliferative breast lesions, we reevaluated 10,366 consecutive breast biopsies performed in women who had presented at three Nashville hospitals. The median duration of follow-up was 17 years for 3303 women, 1925 of whom had proliferative disease. This sample contained 84.4 per cent of the patients originally selected for follow-up. Women having proliferative disease without atypical hyperplasia had a risk of cancer that was 1.9 times the risk in women with nonproliferative lesions (95 per cent confidence interval, 1.2 to 2.9). The risk in women with atypical hyperplasia (atypia) was 5.3 times that in women with nonproliferative lesions (95 per cent confidence interval, 3.1 to 8.8). A family history of breast cancer had little effect on the risk in women with nonproliferative lesions. However, the risk in women with atypia and a family history of breast cancer was 11 times that in women who had nonproliferative lesions without a family history (95 per cent confidence interval, 5.5 to 24). Calcification elevated the cancer risk in patients with proliferative disease. Although cysts alone did not substantially elevate the risk, women with both cysts and a family history of breast cancer had a risk 2.7 times higher than that for women without either of these risk factors (95 per cent confidence interval, 1.5 to 4.6). This study demonstrates that the majority of women (70 per cent) who undergo breast biopsy for benign disease are not at increased risk of cancer. However, patients with a clinically meaningful elevation in cancer risk can be identified on the basis of atypical hyperplasia and a family history of breast cancer.
This article has been cited by other articles:
Sakoda, L. C., Blackston, C., Doherty, J. A., Ray, R. M., Lin, M. G., Stalsberg, H., Gao, D. L., Feng, Z., Thomas, D. B., Chen, C.
(2008). Polymorphisms in Steroid Hormone Biosynthesis Genes and Risk of Breast Cancer and Fibrocystic Breast Conditions in Chinese Women. Cancer Epidemiol. Biomarkers Prev.
17: 1066-1073
[Abstract][Full Text]
Poola, I., Abraham, J., Marshalleck, J. J., Yue, Q., Lokeshwar, V. B., Bonney, G., DeWitty, R. L.
(2008). Molecular Risk Assessment for Breast Cancer Development in Patients with Ductal Hyperplasias. Clin. Cancer Res.
14: 1274-1280
[Abstract][Full Text]
Yu, J., Park, A., Morris, E., Liberman, L., Borgen, P. I., King, T. A.
(2008). MRI Screening in a Clinic Population with a Family History of Breast Cancer. Ann. Surg. Oncol.
15: 452-461
[Abstract][Full Text]
Sklair-Levy, M., Sella, T., Alweiss, T., Craciun, I., Libson, E., Mally, B.
(2008). Incidence and Management of Complex Fibroadenomas. Am. J. Roentgenol.
190: 214-218
[Abstract][Full Text]
Lampe, J. W., Nishino, Y., Ray, R. M., Wu, C., Li, W., Lin, M.-G., Gao, D. L., Hu, Y., Shannon, J., Stalsberg, H., Porter, P. L., Frankenfeld, C. L., Wahala, K., Thomas, D. B.
(2007). Plasma Isoflavones and Fibrocystic Breast Conditions and Breast Cancer Among Women in Shanghai, China. Cancer Epidemiol. Biomarkers Prev.
16: 2579-2586
[Abstract][Full Text]
Willey, S. C., Cocilovo, C.
(2007). Screening and Follow-up of the Patient at High Risk for Breast Cancer. Obstet Gynecol
110: 1404-1416
[Abstract][Full Text]
Wells, C A, El-Ayat, G A
(2007). Non-operative breast pathology: apocrine lesions. J. Clin. Pathol.
60: 1313-1320
[Abstract][Full Text]
Doshi, D. J., March, D. E., Crisi, G. M., Coughlin, B. F.
(2007). Complex Cystic Breast Masses: Diagnostic Approach and Imaging-Pathologic Correlation. RadioGraphics
27: S53-S64
[Abstract][Full Text]
Worsham, M. J., Raju, U., Lu, M., Kapke, A., Cheng, J., Wolman, S. R.
(2007). Multiplicity of Benign Breast Lesions Is a Risk Factor for Progression to Breast Cancer. Clin. Cancer Res.
13: 5474-5479
[Abstract][Full Text]
Cui, Y., Vogt, S., Olson, N., Glass, A. G., Rohan, T. E.
(2007). Levels of Zinc, Selenium, Calcium, and Iron in Benign Breast Tissue and Risk of Subsequent Breast Cancer. Cancer Epidemiol. Biomarkers Prev.
16: 1682-1685
[Abstract][Full Text]
Degnim, A. C., Visscher, D. W., Berman, H. K., Frost, M. H., Sellers, T. A., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., de Groen, P. C., Lingle, W. L., Ghosh, K., Penheiter, L., Tlsty, T., Melton, L. J. III, Reynolds, C. A., Hartmann, L. C.
(2007). Stratification of Breast Cancer Risk in Women With Atypia: A Mayo Cohort Study. JCO
25: 2671-2677
[Abstract][Full Text]
Wen, W., Ren, Z., Shu, X. O., Cai, Q., Ye, C., Gao, Y.-T., Zheng, W.
(2007). Expression of Cytochrome P450 1B1 and Catechol-O-Methyltransferase in Breast Tissue and Their Associations with Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev.
16: 917-920
[Abstract][Full Text]
Port, E. R., Park, A., Borgen, P. I., Morris, E., Montgomery, L. L.
(2007). Results of MRI Screening for Breast Cancer in High-Risk Patients with LCIS and Atypical Hyperplasia. Ann. Surg. Oncol.
14: 1051-1057
[Abstract][Full Text]
Ashbeck, E. L., Rosenberg, R. D., Stauber, P. M., Key, C. R.
(2007). Benign Breast Biopsy Diagnosis and Subsequent Risk of Breast Cancer. Cancer Epidemiol. Biomarkers Prev.
16: 467-472
[Abstract][Full Text]
Page, D. L
(2007). Why I became a surgical pathologist with interest in breast disease. J. Clin. Pathol.
60: 251-252
[Abstract][Full Text]
Steinman, S., Wang, J., Bourne, P., Yang, Q., Tang, P.
(2007). Expression of Cytokeratin Markers, ER-alpha, PR, HER-2/neu, and EGFR in Pure Ductal Carcinoma In Situ (DCIS) and DCIS with Co-existing Invasive Ductal Carcinoma (IDC) of the Breast. Annals of Clinical & Laboratory Science
37: 127-134
[Abstract][Full Text]
Tang, P., Wang, X., Schiffhauer, L., Wang, J., Bourne, P., Yang, Q., Quinn, A., Hajdu, S. I.
(2006). Relationship between Nuclear Grade of Ductal Carcinoma in situ and Cell Origin Markers.. Annals of Clinical & Laboratory Science
36: 16-22
[Abstract][Full Text]
Lim, C N, Ho, B C S, Bay, B H, Yip, G, Tan, P H
(2006). Nuclear morphometry in columnar cell lesions of the breast: is it useful?. J. Clin. Pathol.
59: 1283-1286
[Abstract][Full Text]
Ai, L., Kim, W.-J., Kim, T.-Y., Fields, C. R., Massoll, N. A., Robertson, K. D., Brown, K. D.
(2006). Epigenetic Silencing of the Tumor Suppressor Cystatin M Occurs during Breast Cancer Progression. Cancer Res.
66: 7899-7909
[Abstract][Full Text]
Poola, I., Shokrani, B., Bhatnagar, R., DeWitty, R. L., Yue, Q., Bonney, G.
(2006). Expression of Carcinoembryonic Antigen Cell Adhesion Molecule 6 Oncoprotein in Atypical Ductal Hyperplastic Tissues Is Associated with the Development of Invasive Breast Cancer. Clin. Cancer Res.
12: 4773-4783
[Abstract][Full Text]
Cazzaniga, M., Severi, G., Casadio, C., Chiapparini, L., Veronesi, U., Decensi, A.
(2006). Atypia and ki-67 expression from ductal lavage in women at different risk for breast cancer.. Cancer Epidemiol. Biomarkers Prev.
15: 1311-1315
[Abstract][Full Text]
Guray, M., Sahin, A. A.
(2006). Benign breast diseases: classification, diagnosis, and management.. The Oncologist
11: 435-449
[Abstract][Full Text]
Ding, L., Erdmann, C., Chinnaiyan, A. M., Merajver, S. D., Kleer, C. G.
(2006). Identification of EZH2 as a Molecular Marker for a Precancerous State in Morphologically Normal Breast Tissues.. Cancer Res.
66: 4095-4099
[Abstract][Full Text]
Miki, Y., Suzuki, T., Kitada, K., Yabuki, N., Shibuya, R., Moriya, T., Ishida, T., Ohuchi, N., Blumberg, B., Sasano, H.
(2006). Expression of the Steroid and Xenobiotic Receptor and Its Possible Target Gene, Organic Anion Transporting Polypeptide-A, in Human Breast Carcinoma. Cancer Res.
66: 535-542
[Abstract][Full Text]
Baker, J. A., Beehler, G. P., Sawant, A. C., Jayaprakash, V., McCann, S. E., Moysich, K. B.
(2006). Consumption of Coffee, but Not Black Tea, Is Associated with Decreased Risk of Premenopausal Breast Cancer. J. Nutr.
136: 166-171
[Abstract][Full Text]
van Duijnhoven, F. J.B., Bezemer, I. D., Peeters, P. H.M., Roest, M., Uitterlinden, A. G., Grobbee, D. E., van Gils, C. H.
(2005). Polymorphisms in the Estrogen Receptor {alpha} Gene and Mammographic Density. Cancer Epidemiol. Biomarkers Prev.
14: 2655-2660
[Abstract][Full Text]
Kristiansen, I. S., Fineberg, S., Kristiansen, I. S., Christensen, P. M., Gyrd-Hansen, D., Visscher, D. W., Degnim, A. C., Hartmann, L. C., Elmore, J. G., Gigerenzer, G.
(2005). Benign breast disease and breast cancer.. NEJM
353: 1856-1858
[Full Text]
Arpino, G., Laucirica, R., Elledge, R. M.
(2005). Premalignant and In Situ Breast Disease: Biology and Clinical Implications. ANN INTERN MED
143: 446-457
[Abstract][Full Text]
Gottlieb, S.
(2005). Women with benign breast disease face higher cancer risk. BMJ
331: 179-179
[Full Text]
Hartmann, L. C., Sellers, T. A., Frost, M. H., Lingle, W. L., Degnim, A. C., Ghosh, K., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., Hillman, D. W., Suman, V. J., Johnson, J., Blake, C., Tlsty, T., Vachon, C. M., Melton, L. J. III, Visscher, D. W.
(2005). Benign Breast Disease and the Risk of Breast Cancer. NEJM
353: 229-237
[Abstract][Full Text]
Schairer, C., Hill, D., Sturgeon, S. R., Fears, T., Mies, C., Ziegler, R. G., Hoover, R. N., Sherman, M. E.
(2005). Serum Concentrations of Estrogens, Sex Hormone Binding Globulin, and Androgens and Risk of Breast Hyperplasia in Postmenopausal Women. Cancer Epidemiol. Biomarkers Prev.
14: 1660-1665
[Abstract][Full Text]
Fabian, C J, Kimler, B F, Mayo, M S, Khan, S A
(2005). Breast-tissue sampling for risk assessment and prevention. Endocr Relat Cancer
12: 185-213
[Abstract][Full Text]
Esslimani-Sahla, M., Kramar, A., Simony-Lafontaine, J., Warner, M., Gustafsson, J.-A., Rochefort, H.
(2005). Increased Estrogen Receptor {beta}cx Expression during Mammary Carcinogenesis. Clin. Cancer Res.
11: 3170-3174
[Abstract][Full Text]
Khan, Q. J., Kimler, B. F., Clark, J., Metheny, T., Zalles, C. M., Fabian, C. J.
(2005). Ki-67 Expression in Benign Breast Ductal Cells Obtained by Random Periareolar Fine Needle Aspiration. Cancer Epidemiol. Biomarkers Prev.
14: 786-789
[Abstract][Full Text]
Frech, M. S., Halama, E. D., Tilli, M. T., Singh, B., Gunther, E. J., Chodosh, L. A., Flaws, J. A., Furth, P. A.
(2005). Deregulated Estrogen Receptor {alpha} Expression in Mammary Epithelial Cells of Transgenic Mice Results in the Development of Ductal Carcinoma In situ. Cancer Res.
65: 681-685
[Abstract][Full Text]
Muller-Decker, K., Berger, I., Ackermann, K., Ehemann, V., Zoubova, S., Aulmann, S., Pyerin, W., Furstenberger, G.
(2005). Cystic Duct Dilatations and Proliferative Epithelial Lesions in Mouse Mammary Glands upon Keratin 5 Promoter-Driven Overexpression of Cyclooxygenase-2. Am. J. Pathol.
166: 575-584
[Abstract][Full Text]
Ozanne, E. M., Esserman, L. J.
(2004). Evaluation of Breast Cancer Risk Assessment Techniques: A Cost-effectiveness Analysis. Cancer Epidemiol. Biomarkers Prev.
13: 2043-2052
[Abstract][Full Text]
Arun, B.
(2004). Ductal Lavage and Risk Assessment of Breast Cancer. The Oncologist
9: 599-605
[Abstract][Full Text]
Ford, C. E., Faedo, M., Crouch, R., Lawson, J. S., Rawlinson, W. D.
(2004). Progression from Normal Breast Pathology to Breast Cancer Is Associated with Increasing Prevalence of Mouse Mammary Tumor Virus-Like Sequences in Men and Women. Cancer Res.
64: 4755-4759
[Abstract][Full Text]
Webb, P. M., Byrne, C., Schnitt, S. J., Connolly, J. L., Jacobs, T. W., Baer, H. J., Willett, W. C., Colditz, G. A.
(2004). A Prospective Study of Diet and Benign Breast Disease. Cancer Epidemiol. Biomarkers Prev.
13: 1106-1113
[Abstract][Full Text]
Wang, J., Costantino, J. P., Tan-Chiu, E., Wickerham, D. L., Paik, S., Wolmark, N.
(2004). Lower-Category Benign Breast Disease and the Risk of Invasive Breast Cancer. JNCI J Natl Cancer Inst
96: 616-620
[Abstract][Full Text]
Cook, I S, Fuller, C E
(2004). Does histopathological examination of breast reduction specimens affect patient management and clinical follow up?. J. Clin. Pathol.
57: 286-289
[Abstract][Full Text]
Cooper, M., Li, S.-Q., Bhardwaj, T., Rohan, T., Kandel, R. A.
(2004). Evaluation of Oligonucleotide Arrays for Sequencing of the p53 Gene in DNA from Formalin-Fixed, Paraffin-Embedded Breast Cancer Specimens. Clin. Chem.
50: 500-508
[Abstract][Full Text]
Suter, N. M., Ray, R. M., Hu, Y. W., Lin, M. G., Porter, P., Gao, D. L., Zaucha, R. E., Iwasaki, L. M., Sabacan, L. P., Langlois, M. C., Thomas, D. B., Ostrander, E. A.
(2004). BRCA1 and BRCA2 Mutations in Women from Shanghai China. Cancer Epidemiol. Biomarkers Prev.
13: 181-189
[Abstract][Full Text]
Kallianpur, A. R., Hall, L. D., Yadav, M., Christman, B. W., Dittus, R. S., Haines, J. L., Parl, F. F., Summar, M. L.
(2004). Increased Prevalence of the HFE C282Y Hemochromatosis Allele in Women with Breast Cancer. Cancer Epidemiol. Biomarkers Prev.
13: 205-212
[Abstract][Full Text]
Gutman, H., Schachter, J., Wasserberg, N., Shechtman, I., Greiff, F.
(2003). Are Solitary Breast Papillomas Entirely Benign?. Arch Surg
138: 1330-1333
[Abstract][Full Text]
Baer, H. J., Schnitt, S. J., Connolly, J. L., Byrne, C., Cho, E., Willett, W. C., Colditz, G. A.
(2003). Adolescent Diet and Incidence of Proliferative Benign Breast Disease. Cancer Epidemiol. Biomarkers Prev.
12: 1159-1167
[Abstract][Full Text]
Lin, E. Y., Jones, J. G., Li, P., Zhu, L., Whitney, K. D., Muller, W. J., Pollard, J. W.
(2003). Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases. Am. J. Pathol.
163: 2113-2126
[Abstract][Full Text]
Winchester, D. J., Bernstein, J. R., Jeske, J. M., Nicholson, M. H., Hahn, E. A., Goldschmidt, R. A., Watkin, W. G., Sener, S. F., Bilimoria, M. B., Barrera, E. Jr, Winchester, D. P.
(2003). Upstaging of Atypical Ductal Hyperplasia After Vacuum-Assisted 11-Gauge Stereotactic Core Needle Biopsy. Arch Surg
138: 619-623
[Abstract][Full Text]
Ford, C. E., Tran, D., Deng, Y., Ta, V. T., Rawlinson, W. D., Lawson, J. S.
(2003). Mouse Mammary Tumor Virus-like Gene Sequences in Breast Tumors of Australian and Vietnamese Women. Clin. Cancer Res.
9: 1118-1120
[Abstract][Full Text]
Tan-Chiu, E., Wang, J., Costantino, J. P., Paik, S., Butch, C., Wickerham, D. L., Fisher, B., Wolmark, N.
(2003). Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer. JNCI J Natl Cancer Inst
95: 302-307
[Abstract][Full Text]
Domchek, S. M., Eisen, A., Calzone, K., Stopfer, J., Blackwood, A., Weber, B. L.
(2003). Application of Breast Cancer Risk Prediction Models in Clinical Practice. JCO
21: 593-601
[Abstract][Full Text]
Hoogerbrugge, N., Bult, P., de Widt-Levert, L.M., Beex, L.V., Kiemeney, L.A., Ligtenberg, M.J.L., Massuger, L.F., Boetes, C., Manders, P., Brunner, H.G.
(2003). High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer. JCO
21: 41-45
[Abstract][Full Text]
Evans, D G R, Lalloo, F
(2002). Risk assessment and management of high risk familial breast cancer. J. Med. Genet.
39: 865-871
[Abstract][Full Text]
Byrne, C., Webb, P. M., Jacobs, T. W., Peiro, G., Schnitt, S. J., Connolly, J. L., Willett, W. C., Colditz, G. A.
(2002). Alcohol Consumption and Incidence of Benign Breast Disease. Cancer Epidemiol. Biomarkers Prev.
11: 1369-1374
[Abstract][Full Text]
Thomas, D. B., Carter, R. A., Bush, W. H. Jr., Ray, R. M., Stanford, J. L., Lehman, C. D., Daling, J. R., Malone, K., Davis, S.
(2002). Risk of Subsequent Breast Cancer in Relation to Characteristics of Screening Mammograms from Women Less Than 50 Years of Age. Cancer Epidemiol. Biomarkers Prev.
11: 565-571
[Abstract][Full Text]
Shaaban, A. M., Sloane, J. P., West, C. R., Foster, C. S.
(2002). Breast Cancer Risk in Usual Ductal Hyperplasia Is Defined by Estrogen Receptor-{alpha} and Ki-67 Expression. Am. J. Pathol.
160: 597-604
[Abstract][Full Text]
Hershman, D., Sundararajan, V., Jacobson, J. S., Heitjan, D. F., Neugut, A. I., Grann, V. R.
(2002). Outcomes of Tamoxifen Chemoprevention for Breast Cancer in Very High-Risk Women: A Cost-Effectiveness Analysis. JCO
20: 9-16
[Abstract][Full Text]
Wrensch, M. R., Petrakis, N. L., Miike, R., King, E. B., Chew, K., Neuhaus, J., Lee, M. M., Rhys, M.
(2001). Breast Cancer Risk in Women With Abnormal Cytology in Nipple Aspirates of Breast Fluid. JNCI J Natl Cancer Inst
93: 1791-1798
[Abstract][Full Text]
Dooley, W. C., Ljung, B.-M., Veronesi, U., Cazzaniga, M., Elledge, R. M., O'Shaughnessy, J. A., Kuerer, H. M., Hung, D. T., Khan, S. A., Phillips, R. F., Ganz, P. A., Euhus, D. M., Esserman, L. J., Haffty, B. G., King, B. L., Kelley, M. C., Anderson, M. M., Schmit, P. J., Clark, R. R., Kass, F. C., Anderson, B. O., Troyan, S. L., Arias, R. D., Quiring, J. N., Love, S. M., Page, D. L., King, E. B.
(2001). Ductal Lavage for Detection of Cellular Atypia in Women at High Risk for Breast Cancer. JNCI J Natl Cancer Inst
93: 1624-1632
[Abstract][Full Text]
Franco, N., Picard, S.-F., Mege, F., Arnould, L., Lizard-Nacol, S.
(2001). Absence of Genetic Abnormalities in Fibroadenomas of the Breast Determined at p53 Gene Mutations and Microsatellite Alterations. Cancer Res.
61: 7955-7958
[Abstract][Full Text]
Lakhani, S R
(2001). Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer. Mol. Pathol.
54: 281-284
[Abstract][Full Text]
Rajkumar, L., Guzman, R. C., Yang, J., Thordarson, G., Talamantes, F., Nandi, S.
(2001). Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc. Natl. Acad. Sci. USA
98: 11755-11759
[Abstract][Full Text]
Gong, G., DeVries, S., Chew, K. L., Cha, I., Ljung, B.-M., Waldman, F. M.
(2001). Genetic Changes in Paired Atypical and Usual Ductal Hyperplasia of the Breast by Comparative Genomic Hybridization. Clin. Cancer Res.
7: 2410-2414
[Abstract][Full Text]
Maitra, A., Wistuba, I. I., Washington, C., Virmani, A. K., Ashfaq, R., Milchgrub, S., Gazdar, A. F., Minna, J. D.
(2001). High-Resolution Chromosome 3p Allelotyping of Breast Carcinomas and Precursor Lesions Demonstrates Frequent Loss of Heterozygosity and a Discontinuous Pattern of Allele Loss. Am. J. Pathol.
159: 119-130
[Abstract][Full Text]
Starcevic, S. L., Elferink, C., Novak, R. F.
(2001). Progressive Resistance to Apoptosis in a Cell Lineage Model of Human Proliferative Breast Disease. JNCI J Natl Cancer Inst
93: 776-782
[Abstract][Full Text]
Rieger-Christ, K M, Pezza, J A, Dugan, J M, Braasch, J W, Hughes, K S, Summerhayes, I C
(2001). Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol. Pathol.
54: 91-97
[Abstract][Full Text]
Roger, P., Sahla, M. E., Mäkelä, S., Gustafsson, J. A., Baldet, P., Rochefort, H.
(2001). Decreased Expression of Estrogen Receptor {beta} Protein in Proliferative Preinvasive Mammary Tumors. Cancer Res.
61: 2537-2541
[Abstract][Full Text]
Smedira, H. J.
(2000). Practical Issues in Counseling Healthy Women About Their Breast Cancer Risk and Use of Tamoxifen Citrate. Arch Intern Med
160: 3034-3042
[Abstract][Full Text]
Shoker, B S, Jarvis, C, Clarke, R B, Anderson, E, Munro, C, Davies, M P A, Sibson, D R, Sloane, J P
(2000). Abnormal regulation of the oestrogen receptor in benign breast lesions. J. Clin. Pathol.
53: 778-783
[Abstract][Full Text]
Friedenreich, C., Bryant, H., Alexander, F, Hugh, J, Danyluk, J, Page, D.
(2000). Risk factors for benign proliferative breast disease. Int J Epidemiol
29: 637-644
[Abstract][Full Text]
Tibiletti, M. G., Sessa, F., Bernasconi, B., Cerutti, R., Broggi, B., Furlan, D., Acquati, F., Bianchi, M., Russo, A., Capella, C., Taramelli, R.
(2000). A Large 6q Deletion Is a Common Cytogenetic Alteration in Fibroadenomas, Pre-malignant Lesions, and Carcinomas of the Breast. Clin. Cancer Res.
6: 1422-1431
[Abstract][Full Text]
Armstrong, K., Eisen, A., Weber, B.
(2000). Assessing the Risk of Breast Cancer. NEJM
342: 564-571
[Full Text]
Cui, X., Feiner, H., Lin, Z., Li, H.
(2000). Multiplex Genotype Analysis of Invasive Carcinoma and Accompanying Proliferative Lesions Microdissected from Breast Tissue. J. Mol. Diagn.
2: 29-36
[Abstract][Full Text]
Stark, A., Hulka, B. S., Joens, S., Novotny, D., Thor, A. D., Wold, L. E., Schell, M. J., Melton, L. J. III, Liu, E. T., Conway, K.
(2000). HER-2/neu Amplification in Benign Breast Disease and the Risk of Subsequent Breast Cancer. JCO
18: 267-267
[Abstract][Full Text]
Aronson, K. J., Miller, A. B., Woolcott, C. G., Sterns, E. E., McCready, D. R., Lickley, L. A., Fish, E. B., Hiraki, G. Y., Holloway, C., Ross, T., Hanna, W. M., SenGupta, S. K., Weber, J.-P.
(2000). Breast Adipose Tissue Concentrations of Polychlorinated Biphenyls and Other Organochlorines and Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev.
9: 55-63
[Abstract][Full Text]
Ellis, M. J., Hayes, D. F.
(1999). Refining Breast Cancer Risk Assessment With Molecular Markers: the Next Step?. JNCI J Natl Cancer Inst
91: 2067-2068
[Full Text]
Gobbi, H., Dupont, W. D., Simpson, J. F., Plummer, W.D. Jr., Schuyler, P. A., Olson, S. J., Arteaga, C. L., Page, D. L.
(1999). Transforming Growth Factor-{beta} and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia. JNCI J Natl Cancer Inst
91: 2096-2101
[Abstract][Full Text]
Shoker, B. S., Jarvis, C., Clarke, R. B., Anderson, E., Hewlett, J., Davies, M. P. A., Sibson, D. R., Sloane, J. P.
(1999). Estrogen Receptor-Positive Proliferating Cells in the Normal and Precancerous Breast. Am. J. Pathol.
155: 1811-1815
[Abstract][Full Text]
Garber, J.
(1999). A 40-Year-Old Woman With a Strong Family History of Breast Cancer. JAMA
282: 1953-1960
[Full Text]
Barton, M. B., Harris, R., Fletcher, S. W.
(1999). Does This Patient Have Breast Cancer?: The Screening Clinical Breast Examination: Should It Be Done? How?. JAMA
282: 1270-1280
[Abstract][Full Text]
Gertig, D. M., Stillman, I. E., Byrne, C., Spiegelman, D., Schnitt, S. J., Connolly, J. L., Colditz, G. A., Hunter, D. J.
(1999). Association of Age and Reproductive Factors with Benign Breast Tissue Composition. Cancer Epidemiol. Biomarkers Prev.
8: 873-879
[Abstract][Full Text]
Jordan, V. C., Morrow, M.
(1999). Tamoxifen, Raloxifene, and the Prevention of Breast Cancer. Endocr. Rev.
20: 253-278
[Abstract][Full Text]
Jacobs, T. W., Byrne, C., Colditz, G., Connolly, J. L., Schnitt, S. J.
(1999). Radial Scars in Benign Breast-Biopsy Specimens and the Risk of Breast Cancer. NEJM
340: 430-436
[Abstract][Full Text]
Cyrlak, D., Carpenter, P. M., Rawal, N. B.
(1999). Breast Imaging Case of the Day. RadioGraphics
19: 245-247
[Full Text]
Hortobagyi, G. N.
(1998). Treatment of Breast Cancer. NEJM
339: 974-984
[Full Text]
Dupont, W. D., Page, D. L., Parl, F. F., Vnencak-Jones, C. L., Plummer, W. D., Rados, M. S., Schuyler, P. A.
(1994). Long-Term Risk of Breast Cancer in Women with Fibroadenoma. NEJM
331: 10-15
[Abstract][Full Text]
Evans, D G R, Fentiman, I S, McPherson, K, Asbury, D, Ponder, B A J, Howell, A
(1994). Fortnightly Review: Familial breast cancer. BMJ
308: 183-187
[Abstract][Full Text]
Skolnick, M., Cannon-Albright, L., Goldgar, D., Ward, J., Marshall, C., Schumann, G., Hogle, H, McWhorter, W., Wright, E., Tran, T., et, al.
(1990). Inheritance of proliferative breast disease in breast cancer kindreds. Science
250: 1715-1720
[Abstract]
Previous
